Filing Flows › Usana Health Sciences (USNA) › How it makes money
How Usana Health Sciences (USNA) makes money
Usana Health Sciences (USNA) made $223M of revenue in the second quarter 2026 (Q2 2026), -5% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $223M | 100.0% |
| Income tax | $9.1M | 4.1% |
| Operating cash flow | $23.3M | 10.4% |
| Free cash flow | $20.2M | 9.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $223M | -5% |
| Q1 2026 | $250M | +0.3% |
| Q4 2025 | $226M | +6% |
| Q3 2025 | $214M | +7% |
| Q2 2025 | $236M | +11% |
| Q1 2025 | $250M | +10% |
| Q4 2024 | $214M | -3% |
From Usana Health Sciences' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Usana Health Sciences make money?
Usana Health Sciences (USNA) made $223M of revenue in the second quarter 2026 (Q2 2026), -5% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.